Purpose-led, Performance-driven

DSM is a global science-based company operating in the fields of Nutrition, Health and Sustainable Living. Our business is centered around developing innovative solutions and large innovation projects addressing Nutrition & Health, Climate & Energy and Resources & Circularity to drive above market growth.

Why invest in DSM?

DSM is positioned to drive continued above market organic growth and deliver further improvement in profitability, shareholder return and sustainability as we execute Strategy 2021.

Results center

The Annual Results published on 13 February confirm DSM delivered a good financial performance for the year and achieved the key milestones in the first year of its Strategy 2021.

Share center

In 2019 DSM celebrated the 30th anniversary of its privatisation and our ordinary shares being listed on the Euronext Stock Exchange in Amsterdam, the Netherlands.

Nutrition

We provide nutritional solutions for animal health and human well-being, serving the global feed, food & beverage, pharmaceutical, infant nutrition, dietary supplements and personal care industries.

Animal Nutrition & Health

2019
Sales: ↑€2,892 (2018: €2,749)
Organic Growth: ↑4%
Volume Growth: ↑2%
Price Growth: ↑2%

Human Nutrition

2019
Sales: ↑€2,046 (2018: €1,989)
Organic Growth: ↓1%
Volume Growth: ↑2%
Price Growth: ↓3%

Food Specialties

2019
Sales: ↑€572 (2018: €490)
Sales: ↑17%
Organic Growth: ↑4

Personal Care

2019
Sales: ↑€425 (2018: €382)
Sales: ↑11%
Organic Growth: ↑9%

Sales1
€6,028m

Adjusted EBITDA1
€1,250M

Adjusted EBITDA Margin1
20.7%

1) Underlying business, net of temporary vitamin effect

Materials

Advanced and high-performance materials for the electrical & electronics, automotive, packaging, consumer goods, life protection, transportation and telecom industries.

DSM Engineering Materials

2019
Sales: ↓€1,406 (2018: €1,516)
Organic Growth: ↓10%

DSM Protective Materials

2019
Sales: ↓€338 (2018: €344)
Organic Growth: ↓4%

DSM Resins

2019
Sales: ↓€1,002 (2018: €1,053)
Organic Growth: ↓6%

Sales
€2,746M

Adjusted EBITDA
€509M

Adjusted EBITDA Margin
18.5%

Latest financial & regulatory news

Investor contacts

Our Investor Relations team are based in Heerlen, the Netherlands. The team provides key facts and figures, as well as shareholder information, to current and potential shareholders of DSM and to analysts. To that effect Investor Relations plans, prepares and organizes the written and oral communications with (potential) shareholders and financial analysts, deals with the stock exchange authorities and maintains the necessary databases, websites and brochures. 

Dave Huizing

Vice President
Investor Relations
+31 45 578 2864

Sandra Segers

PA to Dave Huizing
Investor Relations
+31 45 578 2864

Anna Morello

Manager
Investor Relations
+31 45 578 2282

Marc Silvertand

Manager
Investor Relations
+31 45 578 2348

Daniel Uribe

Analyst
Investor Relations
+31 45 578 2864

Petra Volk

Support Officer
Investor Relations
+31 45 578 2511

Read more

  • At a glance

    Key facts and figures about DSM, our business and our people, planet & profit performance in one overview.

  • Factbooks

    An introduction for investors and analysts to DSM, our Nutrition, Materials and Innovation Center clusters and our businesses.

  • Corporate Governance

    We believe in doing business the right way: from our management and supervisory boards, to our code of business conduct, to our position papers and statements on key industry issues.

This site uses cookies to optimize your user experience.

Read more